*	OR T2 T3
R1	Has_mood Arg1:T4 Arg2:T2	
*	OR T7 T6
R2	Subsumes Arg1:T9 Arg2:T10	
R3	Has_multiplier Arg1:T9 Arg2:T8	
R4	AND Arg1:T11 Arg2:T9	
R5	Has_mood Arg1:T13 Arg2:T14	
T1	Visit 27 56	participating research centre
T2	Mood 62 74	suspicion of
T3	Qualifier 78 87	confirmed
T4	Condition 88 106	endometrial cancer
T6	Condition 138 163	epithelial ovarian cancer
T7	Condition 123 134;149 163	endometrial ovarian cancer
T8	Multiplier 218 224	weekly
T9	Drug 225 231	taxane
T10	Drug 233 243	paclitaxel
T11	Procedure 245 254	treatment
T12	Non-representable 256 345	This will often be a third or fourth line treatment, i.e. patients with advanced disease.
T13	Procedure 385 398	tissue biopsy
T14	Mood 347 378	Technical possibility to obtain
T15	Condition 434 451	tumour recurrence
